Doctors find "clear evidence" it improves coronavirus symptoms.
The antiviral drug, called Favipiravir or Avigan, showed positive outcomes in clinical trials involving 340 individuals in Wuhan and Shenzhen, said Zhang Xinmin, of China's science and technology ministry, according to The Guardian.
"It has a high degree of safety and is clearly effective in treatment," Zhang said Tuesday (March 17), The Guardian reported.
Developed by Fujifilm Toyama Chemical, the antiviral drug is being manufactured by Zhejiang Hisun Pharmaceutical for treating influenza viruses. Last month, the drug reportedly received approval as an experimental treatment for COVID-19 infections, Pharmaceutical Technology reported.
Consider taking this short risk assessment for the disease - COVID-19, which includes information on drugs that lower your ability to fight the coronavirus.
https://hipaa.jotform.com/200757203859156
Stay Well
Thomas J. Lewis, Ph.D.